Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Altimmune, Inc.

NASDAQ: ALT · Life Sciences · 8 alerts · CIK 1326190

Share price
$1.56Close, Nov 16
Market cap
$304M
Shares outstanding
194.59MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Altimmune, Inc. filings on SEC EDGAR ↗

4:28 PM ET Form 4
Insider Buying

Altimmune CFO Gregory L. Weaver Buys $16.2K of Stock

Gregory L. Weaver, CFO, bought 10,000 shares of Altimmune, Inc. at $1.62 a share, worth $16.2K in total on Nov 13, 2026. Shares held after the trade: 73,005 (+15.9%).

Value
$16.2K
Shares
10,000
Price
$1.62
Role
CFO
Holding change
+15.9%
Trade date
Nov 13, 2026
4:27 PM ET Form 4
Insider Buying

Altimmune Director Wayne Pisano Buys $16.4K of Stock

Wayne Pisano, Director, bought 10,000 shares of Altimmune, Inc. at $1.64 a share, worth $16.4K in total on Nov 13, 2026. Shares held after the trade: 58,800 (+20.5%).

Value
$16.4K
Shares
10,000
Price
$1.64
Role
Director
Holding change
+20.5%
Trade date
Nov 13, 2026
4:27 PM ET Form 4
Insider Buying

Altimmune President and CEO Jerome Benedict Durso Buys $49.7K of Stock

Jerome Benedict Durso, President and CEO, bought 30,700 shares of Altimmune, Inc. at $1.62 a share, worth $49.7K in total on Nov 13, 2026. Shares held after the trade: 93,200 (+49.1%).

Value
$49.7K
Shares
30,700
Price
$1.62
Role
President and CEO
Holding change
+49.1%
Trade date
Nov 13, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.